ArticleBlood2023

PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy.

Peter G Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.